NO894210L - Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. - Google Patents

Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.

Info

Publication number
NO894210L
NO894210L NO89894210A NO894210A NO894210L NO 894210 L NO894210 L NO 894210L NO 89894210 A NO89894210 A NO 89894210A NO 894210 A NO894210 A NO 894210A NO 894210 L NO894210 L NO 894210L
Authority
NO
Norway
Prior art keywords
quinolyloxazol
oner
procedure
preparation
Prior art date
Application number
NO89894210A
Other languages
English (en)
Norwegian (no)
Other versions
NO894210D0 (no
Inventor
Winton Dennis Jones
Richard Cyrus Dage
George Philip Claxton
Hsien Chang Cheng
Phillip James Robinson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO894210D0 publication Critical patent/NO894210D0/no
Publication of NO894210L publication Critical patent/NO894210L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO89894210A 1988-10-24 1989-10-23 Fremgangsmaate for fremstilling av kinolyloxazol-2-oner. NO894210L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/261,435 US4886811A (en) 1988-10-24 1988-10-24 Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Publications (2)

Publication Number Publication Date
NO894210D0 NO894210D0 (no) 1989-10-23
NO894210L true NO894210L (no) 1990-04-25

Family

ID=22993289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894210A NO894210L (no) 1988-10-24 1989-10-23 Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.

Country Status (21)

Country Link
US (1) US4886811A (da)
EP (1) EP0365863B1 (da)
JP (2) JP2879454B2 (da)
KR (1) KR0162637B1 (da)
CN (1) CN1025854C (da)
AR (1) AR246733A1 (da)
AT (1) ATE110074T1 (da)
AU (1) AU613302B2 (da)
CA (1) CA2000804C (da)
DE (1) DE68917556T2 (da)
DK (1) DK461389A (da)
ES (1) ES2061863T3 (da)
FI (1) FI93112C (da)
HU (1) HUT58088A (da)
IE (1) IE893011L (da)
IL (1) IL91788A (da)
NO (1) NO894210L (da)
NZ (1) NZ230718A (da)
PH (1) PH27450A (da)
PT (1) PT91870B (da)
ZA (1) ZA897259B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
US5190957A (en) * 1989-11-13 1993-03-02 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
PH27309A (en) * 1989-11-13 1993-05-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
ZA908936B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JPH08510451A (ja) * 1993-05-13 1996-11-05 ネオルックス コーポレイション 異常増殖性平滑筋細胞に関連した病因の予防及び治療
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB9929216D0 (en) * 1999-12-11 2000-02-02 Univ Bristol Isoquinoline and Quinoline Containing substances
WO2006130090A1 (en) * 2005-06-03 2006-12-07 Pronas Pharma Ab Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025215A (en) * 1959-07-29 1962-03-13 Monsanto Chemicals Bis (8-quinolyl carbonate) derivatives
US3857877A (en) * 1973-01-12 1974-12-31 Karamchand Premchand Private 8-hydroxy quinoline derivatives
US4565820A (en) * 1980-07-28 1986-01-21 Pfizer Inc. Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles

Also Published As

Publication number Publication date
AU4249389A (en) 1990-04-26
CN1025854C (zh) 1994-09-07
CA2000804C (en) 1999-04-06
FI93112C (fi) 1995-02-27
JPH11152285A (ja) 1999-06-08
CN1042145A (zh) 1990-05-16
IL91788A (en) 1994-04-12
EP0365863A3 (en) 1990-11-07
EP0365863A2 (en) 1990-05-02
DK461389A (da) 1990-04-25
KR900006307A (ko) 1990-05-07
JPH02164878A (ja) 1990-06-25
FI93112B (fi) 1994-11-15
NZ230718A (en) 1990-11-27
AR246733A1 (es) 1994-09-30
HU895410D0 (en) 1990-01-28
AU613302B2 (en) 1991-07-25
JP2879454B2 (ja) 1999-04-05
ZA897259B (en) 1990-07-25
ES2061863T3 (es) 1994-12-16
US4886811A (en) 1989-12-12
EP0365863B1 (en) 1994-08-17
JP2983970B2 (ja) 1999-11-29
NO894210D0 (no) 1989-10-23
IE893011L (en) 1990-04-24
IL91788A0 (en) 1990-06-10
KR0162637B1 (ko) 1998-12-01
DE68917556D1 (de) 1994-09-22
FI894459A0 (fi) 1989-09-20
HUT58088A (en) 1992-01-28
PH27450A (en) 1993-07-02
DK461389D0 (da) 1989-09-19
DE68917556T2 (de) 1994-12-15
FI894459A (fi) 1990-04-25
ATE110074T1 (de) 1994-09-15
PT91870B (pt) 1995-05-31
PT91870A (pt) 1990-04-30
CA2000804A1 (en) 1990-04-24

Similar Documents

Publication Publication Date Title
NO892936L (no) Fremgangsmaate for fremstilling av furanderivater.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO882730D0 (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO170022C (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO880834L (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO890819L (no) Fremgangsmaate for fremstilling av hydroksybenzaldehyder.
NO903254D0 (no) Fremgangsmaate for fremstilling av kinuklidin-derivater.
NO890538L (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO880844L (no) Fremgangsmaate for fremstilling av cytotoksiner.
NO890375L (no) Fremgangsmaate for fremstilling av heksanitrostilben.